Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care

Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care

Abstract Cervical cancer affects over half a million people worldwide each year, the majority of whom are in resource-limited settings where cytology screening is not available. As persistent human papilloma virus (HPV) infections are a key causative factor, detection of HPV strains now complements...

Full description

Bibliographic Details
Main Authors: Benjamin W. Wormald, Nicolas Moser, Nandita M. deSouza, Katerina-Theresa Mantikas, Kenny Malpartida-Cardenas, Ivana Pennisi, Thomas E. J. Ind, Katherine Vroobel, Melpomeni Kalofonou, Jesus Rodriguez-Manzano, Pantelis Georgiou
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-12557-y

Internet

https://doi.org/10.1038/s41598-022-12557-y

Similar Items